BR112015018798A2 - composição antifúngica tópica para tratar onocomicose - Google Patents

composição antifúngica tópica para tratar onocomicose

Info

Publication number
BR112015018798A2
BR112015018798A2 BR112015018798A BR112015018798A BR112015018798A2 BR 112015018798 A2 BR112015018798 A2 BR 112015018798A2 BR 112015018798 A BR112015018798 A BR 112015018798A BR 112015018798 A BR112015018798 A BR 112015018798A BR 112015018798 A2 BR112015018798 A2 BR 112015018798A2
Authority
BR
Brazil
Prior art keywords
onocomycosis
antifungal composition
treat
topical antifungal
treating
Prior art date
Application number
BR112015018798A
Other languages
English (en)
Other versions
BR112015018798B1 (pt
Inventor
Ceriani Daniela
Mailland Frederico
Iob Giuliana
Legora Michela
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50029007&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112015018798(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of BR112015018798A2 publication Critical patent/BR112015018798A2/pt
Publication of BR112015018798B1 publication Critical patent/BR112015018798B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1/1 resumo “composição antifúngica tópica para tratar onocomicose” a presente invenção é direcionada a um esmalte de unha consistindo essencialmente de terbinafina como um agente antimicótico, hidroxipropil quitosano como agente formador de película, água e um alcanol inferior como solventes. a invenção é também direcionada a um método para tratar onocomicose pela administração tópica de um tal esmalte de unha a um paciente em necessidade de um tal tratamento.
BR112015018798-6A 2013-02-07 2014-01-23 Composição antifúngica tópica para tratar onocomicose BR112015018798B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361761953P 2013-02-07 2013-02-07
US61/761,953 2013-02-07
US201361781560P 2013-03-14 2013-03-14
US61/781,560 2013-03-14
PCT/EP2014/051288 WO2014122024A1 (en) 2013-02-07 2014-01-23 Topical antifungal composition for treating onychomycosis

Publications (2)

Publication Number Publication Date
BR112015018798A2 true BR112015018798A2 (pt) 2017-07-18
BR112015018798B1 BR112015018798B1 (pt) 2022-03-29

Family

ID=50029007

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015018798-6A BR112015018798B1 (pt) 2013-02-07 2014-01-23 Composição antifúngica tópica para tratar onocomicose

Country Status (35)

Country Link
US (3) US8697753B1 (pt)
EP (1) EP2953621B1 (pt)
JP (1) JP6420258B2 (pt)
KR (1) KR102200788B1 (pt)
CN (1) CN105050592B (pt)
AU (1) AU2014214166B2 (pt)
BR (1) BR112015018798B1 (pt)
CA (1) CA2900127C (pt)
CL (1) CL2015002191A1 (pt)
CR (1) CR20150377A (pt)
CY (1) CY1121841T1 (pt)
DK (1) DK2953621T3 (pt)
EA (1) EA036061B1 (pt)
EC (1) ECSP15033898A (pt)
ES (1) ES2729373T3 (pt)
HK (1) HK1212904A1 (pt)
HR (1) HRP20191243T1 (pt)
HU (1) HUE045000T2 (pt)
IL (1) IL240334B (pt)
LT (1) LT2953621T (pt)
ME (1) ME03507B (pt)
MX (1) MX361880B (pt)
NZ (1) NZ709668A (pt)
PE (1) PE20151300A1 (pt)
PH (1) PH12015501739A1 (pt)
PL (1) PL2953621T3 (pt)
PT (1) PT2953621T (pt)
RS (1) RS58990B1 (pt)
SG (1) SG11201505275YA (pt)
SI (1) SI2953621T1 (pt)
TN (1) TN2015000316A1 (pt)
TW (1) TWI658839B (pt)
UY (1) UY35307A (pt)
WO (1) WO2014122024A1 (pt)
ZA (1) ZA201504880B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
DE102019003486B4 (de) * 2019-05-17 2021-03-18 L/N Health And Beauty Aps Zusammensetzungen zur Behandlung der Onychomykose
AU2020408342B2 (en) * 2019-12-20 2024-02-22 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Topical pharmaceutical compositions for treating onychomycosis

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883545A (en) 1968-08-31 1975-05-13 Hoechst Ag Certain 1-hydroxy-2-pyridones
AT354187B (de) 1976-11-22 1979-12-27 Hoffmann La Roche Fungizides mittel
ATE10272T1 (de) 1979-08-22 1984-11-15 Sandoz Ag Propenylamine, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre verwendung als arzneimittel.
DE3045915A1 (de) 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045914A1 (de) 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3245784A1 (de) 1982-12-10 1984-06-14 Wella Ag, 6100 Darmstadt Kosmetisches mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere chitosanderivate sowie verfahren zu ihrer herstellung
DE3502833A1 (de) 1985-01-29 1986-07-31 Wella Ag, 6100 Darmstadt Kosmetische mittel auf der basis von quaternaeren chitosanderivaten, neue quaternaere hydroxyethyl-substituierte chitosanderivate sowie verfahren zu ihrer herstellung
DE3513277A1 (de) 1985-04-13 1986-10-23 Wella Ag, 6100 Darmstadt Kosmetische mittel auf der basis von quaternaeren hydroxyalkyl-substituierten chitosanderivaten
DE3687458T2 (de) 1985-11-04 1993-07-29 Owen Galderma Lab Inc Filmbildende arzneimitteltraeger zur verabreichung von arzneimitteln an naegeln
DE3541305A1 (de) 1985-11-22 1987-05-27 Wella Ag Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung
DE3544983A1 (de) 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3545929A1 (de) 1985-12-23 1987-06-25 Ceag Licht & Strom Gehaeuse
SE460713B (sv) 1986-04-22 1989-11-13 Atlas Copco Ab Hydrauliskt momentimpulsverk
US4946870A (en) 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
DE3703760A1 (de) 1987-02-07 1988-08-18 Wella Ag Kosmetisches mittel auf der basis von n-hydroxypropylisopropyletherchitosanen, sowie neue n-hydroxypropylisopropyletherderivate des chitosans
HU200914B (en) 1987-03-09 1990-09-28 Horvath Gyoengyi Lengyelne Process for producing new medical dosage unit suitable for local treatment of fungus infection of nails
DE3720147A1 (de) 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
DE3723811A1 (de) 1987-07-18 1989-01-26 Wella Ag Nagellack auf der basis von o-benzyl-n-hydroxyalkylchitosanen sowie neue o-benzyl-n-hydroxyalkylderivate des chitosans
CA2008775C (en) 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
FR2673537B1 (fr) 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
DE4108664C2 (de) 1991-03-16 1995-03-09 Scheller Cosmetics Gmbh Dr Nagellack und Verwendung desselben
HU223343B1 (hu) 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU219480B (hu) 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
DE4212105A1 (de) 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
JPH05339152A (ja) 1992-06-09 1993-12-21 Nippon Soda Co Ltd 皮膚病変局所投与薬剤含有キトサン誘導体フィルム剤
JPH06211651A (ja) 1993-01-12 1994-08-02 Hisamitsu Pharmaceut Co Inc 爪白癬治療用組成物
DE19518262A1 (de) 1995-05-18 1996-11-21 Hoechst Ag Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen
US5391367A (en) 1993-07-28 1995-02-21 Pfizer Inc. Antifungal nail solution
US5487776A (en) 1994-03-17 1996-01-30 Nimni; Marcel Anti-fungal nail lacquer and method therefor
AU3673195A (en) 1994-10-13 1996-05-06 Hisamitsu Pharmaceutical Co., Inc. External preparation for nail ringworm
JP2951725B2 (ja) 1994-10-13 1999-09-20 久光製薬株式会社 爪白癬用外用組成物
US5696164A (en) 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
DE19503423A1 (de) 1995-02-03 1996-08-08 Beiersdorf Ag Antiadhäsive Wirkstoffe
CA2214531C (en) 1995-03-03 2009-01-20 Solomon B. Margolin Treatment of cytokine growth factor caused disorders
DE19604190A1 (de) 1996-02-06 1997-08-07 Hoechst Ag Nagelwachstumsfördernde Zubereitungen
CA2233570C (en) 1996-08-01 2013-02-19 Dale Wallis Detection, prevention and treatment of papillomatous digital dermatitis
JP4253047B2 (ja) 1996-09-27 2009-04-08 杏林製薬株式会社 被膜形成性抗真菌剤組成物
JP4227677B2 (ja) 1996-12-10 2009-02-18 杏林製薬株式会社 被膜形成性抗真菌剤組成物
FR2761886B1 (fr) 1997-04-14 2000-05-05 Virbac Sa Compositions contenant au moins un polymere cationique et au moins une molecule active contenue dans au moins un vecteur micro ou nanoparticulaire, et leur utilisation pour le traitement de surfaces vivantes ou inertes
US5991438A (en) 1997-07-31 1999-11-23 Hewlett-Packard Company Color halftone error-diffusion with local brightness variation reduction
DK0983037T3 (da) 1998-02-09 2003-09-01 Macrochem Corp Fungicid neglelak
WO1999047140A1 (en) 1998-03-17 1999-09-23 Margolin Solomon B Topical antiseptic compositions and methods
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
DE69918087D1 (de) 1998-04-17 2004-07-22 Bertek Pharm Inc Topische formulierungen zur behandlung von nagel pilzerkrankungen
US6306375B1 (en) 1998-05-01 2001-10-23 The Procter & Gamble Company Long wear nail polish having defined surface properties
US5965111A (en) 1998-05-01 1999-10-12 The Procter & Gamble Company Fast drying water-borne nail polish
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6740326B1 (en) 1998-09-10 2004-05-25 Bioequal Ag Topical nail care compositions
DE19841796A1 (de) 1998-09-12 2000-03-16 Beiersdorf Ag Kombinationen von Antiadhäsiva (Kohlenhydrate) und Mikrobiziden
US6159977A (en) 1998-11-16 2000-12-12 Astan, Inc. Therapeutic anti-fungal nail preparation
ATE249811T1 (de) 1999-02-09 2003-10-15 Cognis Deutschland Gmbh Verwendung von nanoskaligen chitosanen
WO2001013955A1 (en) 1999-08-19 2001-03-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
DE19960632A1 (de) 1999-12-16 2001-07-05 Cognis Deutschland Gmbh Kosmetische Mittel enthaltend natürliche Chitosane
ATE320250T1 (de) 2000-01-03 2006-04-15 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
ATE526917T1 (de) 2000-02-16 2011-10-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzung
DE10011081A1 (de) 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
DE10035991A1 (de) * 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
GB0019283D0 (en) 2000-08-04 2000-09-27 Novartis Ag Organic compounds
JP4899139B2 (ja) 2000-08-10 2012-03-21 株式会社ポーラファルマ 抗真菌医薬組成物
US6676953B2 (en) 2001-01-26 2004-01-13 Don L. Hexamer Antifungal composition and method for human nails
US20030118655A1 (en) 2001-12-21 2003-06-26 Nikhil Kundel Film forming liquid composition
US6921529B2 (en) 2002-07-29 2005-07-26 Joseph C. Maley Treatment modality and method for fungal nail infection
US8404751B2 (en) 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
PL2106805T3 (pl) 2003-03-21 2011-10-31 Nexmed Holdings Inc Przeciwgrzybicza powłoka na paznokcie
EP1491202A1 (en) 2003-06-23 2004-12-29 Polichem S.A. Nail restructuring compositions for topical application
WO2005011565A2 (fr) 2003-07-29 2005-02-10 Pierre Fabre Dermo-Cosmetique Vernis a ongles a action antimycosique
AR045241A1 (es) 2003-08-12 2005-10-19 Novartis Consumer Health Sa Composicion topica que comprende terbinafina e hidrocortisona
US20050238672A1 (en) 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
EP1763341A2 (en) 2004-07-02 2007-03-21 Warner-Lambert Company LLC Compositions and methods for treating pathological infections
FR2892023B1 (fr) 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
EP1958639A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans for the treatment of nail inflammatory diseases
EP1958638A1 (en) 2007-02-14 2008-08-20 Polichem S.A. Use of chitosans to increase nail growth rate
EP1958613A1 (en) 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
US20080261986A1 (en) 2007-03-30 2008-10-23 Friden Phillip M Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
WO2010010470A2 (en) * 2008-07-23 2010-01-28 Tdt, Ltd Methods of administering topical antifungal formulations for the treatment of fungal infections
US7903569B2 (en) 2008-11-25 2011-03-08 At&T Intellectual Property I, L.P. Diagnosing network problems in an IPV6 dual stack network
CA2763911C (en) 2009-05-29 2018-01-30 Palau Pharma, S.A. Azole antifungal compositions
FR2954163B1 (fr) 2009-12-18 2012-03-16 Galderma Pharma Sa Utilisation d'un tensioactif cationique, avantageu-sement amphotere, pour la preparation d'une composition antifongique applicable sur l'ongle
JP5339152B2 (ja) 2009-12-18 2013-11-13 横河電機株式会社 電空変換器
WO2011079234A2 (en) 2009-12-23 2011-06-30 Nuvo Research Inc. Highly permeating terbinafine formulation
EP2345643A1 (en) 2009-12-29 2011-07-20 Polichem S.A. New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
RU2432158C1 (ru) 2010-07-28 2011-10-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Профилактический бактерицидный лак для обработки ногтей
US8697753B1 (en) * 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis

Also Published As

Publication number Publication date
TWI658839B (zh) 2019-05-11
US20150366822A1 (en) 2015-12-24
US8697753B1 (en) 2014-04-15
BR112015018798B1 (pt) 2022-03-29
JP6420258B2 (ja) 2018-11-07
EA036061B1 (ru) 2020-09-22
PH12015501739B1 (en) 2015-10-19
LT2953621T (lt) 2019-06-10
PT2953621T (pt) 2019-06-07
WO2014122024A1 (en) 2014-08-14
DK2953621T3 (da) 2019-06-17
UY35307A (es) 2014-06-30
SI2953621T1 (sl) 2019-07-31
NZ709668A (en) 2020-06-26
ZA201504880B (en) 2016-12-21
EP2953621B1 (en) 2019-05-01
CA2900127A1 (en) 2014-08-14
TN2015000316A1 (en) 2017-01-03
CL2015002191A1 (es) 2016-05-20
ME03507B (me) 2020-04-20
IL240334A0 (en) 2015-09-24
AU2014214166B2 (en) 2018-07-26
IL240334B (en) 2019-11-28
CR20150377A (es) 2015-09-24
CN105050592A (zh) 2015-11-11
JP2016507540A (ja) 2016-03-10
HUE045000T2 (hu) 2019-11-28
ECSP15033898A (es) 2015-11-30
SG11201505275YA (en) 2015-08-28
ES2729373T3 (es) 2019-11-04
AU2014214166A1 (en) 2015-08-13
PE20151300A1 (es) 2015-09-16
PH12015501739A1 (en) 2015-10-19
US10172811B2 (en) 2019-01-08
TW201440810A (zh) 2014-11-01
HK1212904A1 (zh) 2016-06-24
MX2015010203A (es) 2016-04-28
CA2900127C (en) 2021-02-09
EP2953621A1 (en) 2015-12-16
MX361880B (es) 2018-12-18
CN105050592B (zh) 2018-04-24
HRP20191243T1 (hr) 2019-11-01
AU2014214166A2 (en) 2015-09-03
US9107877B2 (en) 2015-08-18
CY1121841T1 (el) 2020-07-31
US20140296347A1 (en) 2014-10-02
PL2953621T3 (pl) 2019-09-30
RS58990B1 (sr) 2019-08-30
KR102200788B1 (ko) 2021-01-13
EA201500830A1 (ru) 2016-05-31
KR20150112969A (ko) 2015-10-07

Similar Documents

Publication Publication Date Title
CO2018001375A2 (es) Composiciones de retinoides tópicos
BR112016007946A2 (pt) combinação farmacêutica, usos da mesma, de plinabulina e de composição, kits ou mistura e método para tratar e/ou prevenir câncer
CR20170014A (es) Métodos para tratar el cáncer con inhibidores de tigit y agentes contra el cáncer
MX2017013983A (es) Uso de agentes activos durante tratamientos quimicos.
PH12015502075B1 (en) Treatment of cataplexy
SG10201810401RA (en) Pharmaceutical combinations for treating cancer
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
BR112017009552A2 (pt) métodos para alvejar o controle transcricional em regiões de super-realçador
CY1121841T1 (el) Τοπικη αντιμυκητιασικη συνθεση για τη θεραπεια της ονυχομυκητιασης
PH12016502352A1 (en) Pharmaceutical composition
MX2017015012A (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
TW201613578A (en) Pharmaceutical combinations
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
BR112017002449A2 (pt) tratamento de sintomas associados com terapia de privação androgênica
MX2016003950A (es) Composicion para rocio topica de halobetasol sin propelente.
PH12016500471A1 (en) Method to treat onychomycosis by hydroxypropyl chitosan
PH12016501661A1 (en) Topical antifungal composition for treating onychomycosis
BR112013023337A2 (pt) hidrocloreto de ambroxol para tratamento de faringite aguda, uso do mesmo, composição aquosa borrifável e dispositivo borrifador para aplicação local
UA106471U (uk) Засіб для лікування дерматологічних захворювань
PL407256A1 (pl) Zastosowanie kompozycji i preparatu zawierających tioprolinę i kwas rozmarynowy, sposób spowalniania, przeciwdziałania, zapobiegania procesowi powstawania plam bielaczych skóry
UA106472U (uk) Засіб для лікування дерматологічних захворювань
UA96802U (uk) Спосіб лікування інволютивних змін шкіри обличчя, ускладнених грибковою інфекцією роду malassezia

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/01/2014, OBSERVADAS AS CONDICOES LEGAIS.